HCPCS Codes Similar to J3404

HCPCS Codes Similar to “J3404” Code.
Injection, zopapogene imadenovec-drba suspension, per therapeutic dose

A9564 Chromic phosphate p-32 suspension, therapeutic, per millicurie Code added date: 20060101 Code effective date: 20060101 TXT \| PDF \| XML \| JSON	J7601 Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
J1950 Injection, leuprolide acetate (for depot suspension), per 3.75 mg Code added date: 19860101 Code effective date: 19970101 TXT \| PDF \| XML \| JSON	J1951 Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg Code added date: 20210701 Code effective date: 20210701 TXT \| PDF \| XML \| JSON
J1954 Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg Code added date: 20230101 Code effective date: 20250701 TXT \| PDF \| XML \| JSON	J3140 Injection, testosterone suspension, up to 50 mg Code added date: 19820101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON
A9543 Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries Code added date: 20060101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	A9545 Iodine i-131 tositumomab, therapeutic, per treatment dose Code added date: 20060101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
A9604 Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries Code added date: 20100101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	C1717 Brachytherapy source, non-stranded, high dose rate iridium-192, per source Code added date: 20010401 Code effective date: 20010401 TXT \| PDF \| XML \| JSON
C1719 Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source Code added date: 20010401 Code effective date: 20010401 TXT \| PDF \| XML \| JSON	C9073 Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Code added date: 20210101 Code effective date: 20210401 TXT \| PDF \| XML \| JSON
C9076 Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Code added date: 20210701 Code effective date: 20211001 TXT \| PDF \| XML \| JSON	C9081 Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Code added date: 20211001 Code effective date: 20220101 TXT \| PDF \| XML \| JSON